All News
Four Lifestyle Changes to Prevent Gout
d
MedPage Today
JAMA Open Network reports that reducing four particular risk factors for gout could slash incident cases in men.
Read Article
Addressing Fatigue in Rheumatoid Arthritis: Dr Eric Dein ( @ejdein1)
#acr20
https://t.co/iKdwJqNlPE https://t.co/2u9pEH0QVq
Links:
Dr. John Cush RheumNow ( View Tweet)
My Experience as a COVID19 Vaccine Trial Participant by Dr. Kathryn Dao ( @KDAO2011)
https://t.co/ILfXLUL8IZ https://t.co/Zd8gsCwnQo
Links:
Dr. John Cush RheumNow ( View Tweet)
Four Lifestyle Changes to Prevent Gout
JAMA Open Network reports that reducing four particular risk factors for gout could slash incident cases in men.
Read more below.
https://t.co/6eYA75TjPx https://t.co/kLG9ANCxB9
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Ken Saag -- RECIPE Study: MMF with Pegloticase
Dr. Jack Cush interviews Dr. Ken Saag about the benefits of adding mycophenolate to your pegloticase regimen in refractory gout patients. #acr20
https://t.co/lpDuahgiVa https://t.co/nb8TqwKP5W
Links:
Dr. John Cush RheumNow ( View Tweet)
Flu and Tofacitinib: Dr. Kathryn ( @KDAO2011) reviews abstract L04 at #ACR20.
https://t.co/JpSflrZ7JU https://t.co/gNaNJC90a6
Links:
Dr. John Cush RheumNow ( View Tweet)
Listen to our latest RheumNow podcast below or find us on SoundCloud, Apple/Android podcasts.
https://t.co/w1g6ePwYPB https://t.co/yUs63hbcW4
Links:
Dr. John Cush RheumNow ( View Tweet)
Outcomes of COVID in Rheumatic Disease Patients: Dr. Eric Dein ( @ejdein1)
#ACR20
https://t.co/rf3baoUUa6 https://t.co/dWpGTJq3nJ
Links:
Dr. John Cush RheumNow ( View Tweet)
ACIP Recommendations for Pfizer Vaccine Candidate by Dr. Rachel Tate ( @uptoTate)
https://t.co/l39qH3LuXm https://t.co/9IO3wr13Qm
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Janet Pope ( @Janetbirdope) reviews Osteoarthritis studies presented at #ACR20.
https://t.co/QMQ8DcsK0s https://t.co/W4w9BcsoCH
Links:
Dr. John Cush RheumNow ( View Tweet)
Join Dr. Irene Blanco as she discusses diversity and inclusion issues, specifically in rheumatology education, along with the activities and resources available via the Equity and Inclusion Hub, at the #ACR20.
https://t.co/xIS5Wg9BnN https://t.co/1yUiZwKPaI
Links:
Dr. John Cush RheumNow ( View Tweet)
Important Gout cohort study of 44 654 US men followed x 26 yrs, shows that 77% of incident gout would have been prevented with thes 4 modifiable risk factors: 1) normal weight, 2) adhere to DASH diet, 3) no alcohol, & 4) no diuretics https://t.co/UsDAN8OykX https://t.co/ivBTb8Nyfw
Links:
Dr. John Cush RheumNow ( View Tweet)
Latest update on the SARS-CoV-2 Vaccine from the ACR. https://t.co/uZ2lmOUigU
Links:
Dr. John Cush RheumNow ( View Tweet)
The RHeumNow Podcast is up! Stop These COVID Mistakes(12.11.20). Loss of life in RA, Predicting Difficult RA, New drugs, COVID vaccine recommendations & what to tell your patients during the pandemic. Watch here>> https://t.co/w1g6ePwYPB or listen here>> https://t.co/Qu39ZLcgkm
Dr. John Cush RheumNow ( View Tweet)
Enthesitis in PsA: Dr. Robert Chao ( @doctorRBC) #ACR20
https://t.co/eSnkat99rP https://t.co/cgzqdeDiU0
Links:
Dr. John Cush RheumNow ( View Tweet)
Belimumab in Lupus Nephritis: Dr. Janet Pope (@Janetbirdope) reviews abstract #1441 presented at the #ACR20.
https://t.co/ZoMslbX5dF https://t.co/jeZvdOjqCO
Links:
Dr. John Cush RheumNow ( View Tweet)
New podcast out! Stop These COVID Mistakes
https://t.co/DPZUT2mqdA https://t.co/GpwTejL83k
Links:
Dr. John Cush RheumNow ( View Tweet)
What's New in Calcium Pyrophosphate Disease? NYU's Dr. Michael Pillinger discusses about Dr. Ann Rosenthal's state of the art talk on calcium pyrophosphate disease at #ACR20.
https://t.co/UDxku4xK0C https://t.co/J661yvO06S
Links:
Dr. John Cush RheumNow ( View Tweet)
New Lyme disease guidelines released by the IDSA, AAN and ACR.
https://t.co/ziK3yRyfLG https://t.co/wP60meu0zj
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatologists: Record your question or case for the RheumNow podcast.
https://t.co/wzNmOzH4VE https://t.co/wgiU30C2Ue
Links:
Dr. John Cush RheumNow ( View Tweet)